Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 12Other solid neoplasm 9Sarcoma 6Gynecologic 5Genitourinary 3Head & Neck 2Tumor-Agnostic 1CNS 1Breast 1

Conditions

Uterine Cervical Neoplasms 2Carcinoma, Ovarian Epithelial 2Endometrial Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
envafolimab × Gynecologic × Clear all
NCT05112991 2026-03-25

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

3D Medicines

Phase 2 Recruiting
108 enrolled
Gynecologic

Endometrial Neoplasms

NCT06010667 2023-08-24

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Hebei Medical University Fourth Hospital

Not yet recruiting
60 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT05879796 2023-05-30

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Peking University Third Hospital

Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Chongqing University Cancer Hospital

Phase 2 Not yet recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Zhongda Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡